More information about the medPhoton partnership, HYPERSCAN with Adaptive Aperture, and the clinical and operational advantages of the MEVION S250 Series will be available at ESTRO booth #2500 in Vienna, Austria, from May 5 – 9, 2017.
About Mevion Medical Systems®
Mevion Medical Systems, Inc. is a leading provider of compact proton therapy systems for cancer care. Mevion is based in Littleton, Massachusetts, with international offices in the Netherlands, Japan and China. For more information, please visit www.mevion.com.
Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About the MEVION S250 Series™
The MEVION S250 Series offers the smallest, most advanced proton therapy solution available today. Its unique gantry-mounted proton accelerator provides superior treatment delivery, reduces complexity and cost, and significantly streamlines operations. No other proton therapy system can match the quality, size, cost and efficiency of the MEVION S250 Series.
The MEVION S250 Series includes:
· MEVION S250 Proton Therapy System®, offering highly stable, next-generation volumetric delivery capabilities
· MEVION S250i Proton Therapy System™ with HYPERSCAN™ with Adaptive Aperture™, overcoming pencil beam scanning uncertainties by delivering robust IMPT treatment at hyper-speed
· MEVION S250mx™, making proton therapy fully scalable, with two, three and four room designs that are inherently redundant and support 100% facility uptime
The MEVION S250i Proton Therapy System with HYPERSCAN with Adaptive Aperture is not yet FDA cleared.
Back to HCB News
